Ayala Pharmaceuticals, Inc. is a clinical-stage oncology company, which engages in developing and commercializing small molecule therapeutics for patients suffering from rare tumors and aggressive cancers. Its lead candidates are the oral gamma secretase inhibitor, AL102, for desmoid tumors, and aspacytarabine (BST-236), a novel proprietary anti-metabolite for first line treatment in unfit acute myeloid leukemia. The company was founded in November 2017 and is headquartered in Monmouth Junction, NJ.
Sector:
Commercial Services
Industry:
Miscellaneous Commercial Services
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Ayala Pharmaceuticals Inc.?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Ayala Pharmaceuticals Inc. market cap is $23.66M.
What is the 52-week high for Ayala Pharmaceuticals Inc.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Ayala Pharmaceuticals Inc. 52 week high is $1.95 as of September 06, 2025.
What is the 52-week low for Ayala Pharmaceuticals Inc.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Ayala Pharmaceuticals Inc. 52 week low is $0.50 as of September 06, 2025.
What is Ayala Pharmaceuticals Inc. stock price today?
Ayala Pharmaceuticals Inc. stock price today is $0.665.
What was Ayala Pharmaceuticals Inc. stock price yesterday?
Ayala Pharmaceuticals Inc. stock price yesterday was $0.555.
What is the PE ratio of Ayala Pharmaceuticals Inc.?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Ayala Pharmaceuticals Inc.’s P/E ratio is -0.06.
What is the Price-to-Book ratio of Ayala Pharmaceuticals Inc.?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Ayala Pharmaceuticals Inc. P/B ratio is 2.6291.
What is the 50-day moving average of Ayala Pharmaceuticals Inc.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Ayala Pharmaceuticals Inc. 50-day moving average is $0.6878.
